Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study.
about
Renal cell carcinoma: Evolving and emerging subtypesPlatinum-induced hearing loss after treatment for childhood cancerOverview and recent advances in the treatment of neuroblastoma.Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screensSecond malignancies in patients with neuroblastoma: the effects of risk-based therapy.Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma.G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenicThe anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells.Impairments that influence physical function among survivors of childhood cancerA systematic review of selected musculoskeletal late effects in survivors of childhood cancer.Might salicylate exert benefits against childhood cancer?Physical and mental health status and health behaviors of childhood cancer survivors: findings from the 2009 BRFSS survey.Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remissionThe role of chest computed tomography (CT) as a surveillance tool in children with high-risk neuroblastoma.The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastomaRadiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating riskPotentially functional polymorphisms in the LIN28B gene contribute to neuroblastoma susceptibility in Chinese children.Osteochondroma in long-term survivors of high-risk neuroblastoma.LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population.Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population.Immunocombination therapy for high-risk neuroblastoma.Neuroblastoma: a review of management and outcome.Ten challenges in the management of neuroblastoma.Emerging drugs for neuroblastoma.At the frontier of progress for paediatric oncology: the neuroblastoma paradigm.Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity.Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.Treatment and outcome of neuroblastoma with intraspinal extension: A systematic review.Life partnerships in childhood cancer survivors, their siblings, and the general population.Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation.Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G1 checkpoint-defective neuroblastoma.Sorafenib downregulates ERK/Akt and STAT3 survival pathways and induces apoptosis in a human neuroblastoma cell lineHealth-Related Quality of Life in Survivors of High-Risk Neuroblastoma After Stem Cell Transplant: A National Population-Based Perspective.Survival and late effects in children with stage 4 neuroblastoma.Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk Neuroblastoma.Reassessing dose constraints of organs at risk in children with abdominal neuroblastoma treated with definitive radiation therapy: a correlation with late toxicity.The cytotoxic effects of lipidic formulated gold porphyrin nanoparticles for the treatment of neuroblastoma.LMO1 polymorphisms reduce neuroblastoma risk in Chinese children: a two-center case-control study.
P2860
Q24629153-7C4B75FD-7D1D-4338-83D6-9DC3E2626400Q26470526-AD7A38C1-25E2-45B5-B39E-06795468071BQ30238693-65F8B685-DF7C-4CD2-8882-A1CB05B2683BQ30987402-62B90A7D-E704-4847-9E6A-7CA7EB3FEEEEQ34543549-1022614A-6D48-4AEB-814D-FCEF37867CCAQ34660375-293B098E-B08F-47DE-83B8-89ED06A8ADA0Q34703990-4B3308BF-0837-44B9-8DC1-9A3B5077662EQ34981973-0BC9AE6A-CA52-4281-A912-C0E37BE86668Q34982031-D2E2C9A7-90A9-40D3-BF49-D47A8C9994EFQ34997000-3BE3F0CF-6AF4-422B-8777-5580A3A6DE4AQ35082766-D90FB5BF-940E-4BEF-93D7-0471BB732C7CQ35108050-609C7B0E-8AA9-40B9-9F08-E2F84379E3A8Q35602134-F8B18D69-9105-4CF0-B819-9D93CF67DCC7Q35904706-95A4E581-8222-480F-B816-53FE34C44E64Q36212437-DC1C4A57-96D3-4762-ABFA-57939C6DC206Q36411061-96C9CB06-C496-43F3-BC02-07D9C7880EB8Q36692848-4BF35E17-2C87-4266-ADD7-7EBE6F5F3B50Q36736612-DBF0D83F-F56E-4A28-AFBB-9AAD50795B1DQ37117136-89CAACEC-E215-468A-8B3B-B112A0AF9EA7Q37145905-500BBB1B-BB4A-46B6-BA45-31E806404525Q37225669-B40B9386-7659-4E1E-8B65-B01D2B5ACAD8Q37641476-3811B1C5-613D-427A-975B-EA0279BA6B40Q37991024-E406B070-1868-44DE-9FCA-9B8096FFB855Q38005038-D2360CC7-05A7-45AE-8FE7-AC965B9A2590Q38029366-FD4406CE-E0F8-4DE2-A7FB-25B6D999F1A3Q38108399-0AEDB6EB-9FE6-42E8-BFA4-A6359FAC32D0Q38161274-AD8BB9EF-FB15-427F-AF6C-765EA9C329F4Q38734933-6E67DFFD-5E29-4794-A857-539FB7C20602Q39052883-10970F93-A6F5-4C44-A76B-A402DB72D657Q39114900-07B29D45-A4AF-4274-8D35-61E71AB24B9EQ39330482-5B4891B0-5AAE-4EE8-8250-3BBC84F09D01Q39391640-F63C1220-36C4-466E-B221-AB69D0A0C522Q39620511-53EB7E17-8A46-412B-81D4-1FD7E9153176Q39701739-150FE3C9-D094-4E43-A3E6-0A783CECA34EQ39749852-832E9E8B-03B0-4625-9883-CF6614B62977Q39971015-4EA8F421-2BBC-45DC-AD35-BDAA0CBE5EFDQ40129277-D70F42DE-7D78-4CC5-A6D5-3CC9F036445EQ41643569-E8F25010-2DCB-4AB2-94C4-D5DFAE80133EQ42095135-B837D4B1-3F67-4C1A-AB6B-68BB9535482EQ42371564-1C83C827-F925-4F7F-81BF-22E858276844
P2860
Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Long-term outcomes in survivor ...... ildhood Cancer Survivor Study.
@ast
Long-term outcomes in survivor ...... ildhood Cancer Survivor Study.
@en
Long-term outcomes in survivor ...... ildhood Cancer Survivor Study.
@nl
type
label
Long-term outcomes in survivor ...... ildhood Cancer Survivor Study.
@ast
Long-term outcomes in survivor ...... ildhood Cancer Survivor Study.
@en
Long-term outcomes in survivor ...... ildhood Cancer Survivor Study.
@nl
prefLabel
Long-term outcomes in survivor ...... ildhood Cancer Survivor Study.
@ast
Long-term outcomes in survivor ...... ildhood Cancer Survivor Study.
@en
Long-term outcomes in survivor ...... ildhood Cancer Survivor Study.
@nl
P2093
P2860
P356
P1476
Long-term outcomes in survivor ...... ildhood Cancer Survivor Study.
@en
P2093
Caroline Laverdière
Charles A Sklar
James G Gurney
Leslie L Robison
Lisa R Diller
Marilyn Stovall
Nai-Kong Cheung
Paul C Nathan
Suzanne Wolden
P2860
P304
P356
10.1093/JNCI/DJP230
P407
P577
2009-07-31T00:00:00Z